13F Data
13F filer · CIK 1990717

TRV GP V, LLC

Boston, MA · filing since Q4 2024 · last filing Aug 10, 2026
Reported value
$498.2M
+$97.2M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $35.6M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedRAPPORT THERAPEUTICS, INC.-854,708-12.0%$-35.6M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $294.0MQ1 2025: $125.1MQ2 2025: $165.7MQ3 2025: $353.5MQ4 2025: $429.2MQ1 2026: $401.0MQ2 2026: $498.2M
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1RAPPORT THERAPEUTICS, INC.COM6,280,525$261.7M52.53%
2SEPTERNA, INC.COM6,215,591$208.2M41.78%
3MAZE THERAPEUTICS, INC.COM950,800$28.4M5.69%